Global Anesthesia CO2 Absorbent Market – Industry Trends and Forecast to 2029

Market Analysis and Size

CO2 absorbents are generally used to absorb exhaled gases during anaesthetic delivery. By decreasing new gas flow to closed-circuit conditions, CO2 absorbent formulations are utilised to reduce anaesthetic waste. Strong bases of potassium hydroxide and sodium hydroxide are present in these absorbents, which aid in the conversion of labile protons from anaesthetic molecules to carbon monoxide (CO).

Data Bridge Market Research analyses that the anesthesia CO2 absorbent market which was USD 67 million in 2021, would rocket up to USD 136.47 million by 2029, and is expected to undergo a CAGR of 9.30% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation      

Market Definition

Anesthesia CO2 Absorbents are medical-grade compounds that are used in closed breathing situations to remove carbon dioxide from breathing gases in order to prevent CO2 retention and poisoning.

Anesthesia CO2 Absorbent Market Dynamics

Drivers

• Increasing incidence of chronic and infectious diseases

 The number of fatal accidents, the number of surgical procedures, and the use of sophisticated anaesthetic instruments and devices are all driving market revenue growth. Other important drivers driving global market expansion include an increase in the global geriatric population and an increase in the prevalence of neurological illnesses, cardiovascular disorders, and respiratory diseases that necessitate surgical intervention. Rising demand for anaesthesia disposables, as well as stricter rules regulating the use of anaesthetic medications and equipment, all help to drive market expansion. For example, the Centers for Disease Control and Prevention (CDC), the Anesthesia Patient Safety Foundation, and a number of other regulatory authorities have enforced anaesthesia disposables safety rules.

• Increased frequency of surgical treatments

Surgical treatment is frequently required for cardiothoracic, orthopaedic, vascular, and neurological diseases or disorders. The rising prevalence of cardiovascular illness, arthritis, and cancer, as well as the increased frequency of surgical treatments such as open-heart surgery for vein blockage therapy, are driving demand for general operations.

• Increased incidence and frequency of accidents

The increased incidence and frequency of accidents and chronic illnesses, as well as the worldwide geriatric population base, are driving market expansion. According to the World Health Organization, chronic obstructive pulmonary disease affects over 65 million individuals worldwide.

Opportunities

Anesthesia CO2 absorbent is a niche market of anaesthesia disposables, with demand predicted to grow as the number of surgeries increases. The global surgical volume is large, according to statistics published by the WHO in partnership with Harvard's Department of Health Policy and Management, accounting for around 234 million procedures per year.

Restraints/Challenges

Furthermore, market restraints in the worldwide anesthesia CO2 absorbent market are competitive limits in agreements among organisations or persons at multiple levels of the manufacturing distribution and department process.

This anesthesia CO2 absorbent market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the anesthesia CO2 absorbent market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Covid-19 impact on Anesthesia CO2 Absorbent Market

The demand for crucial life-saving materials, tools, and equipment is increasing as the COVID-19 epidemic spreads. Over the forecast period, the increased need for anaesthesia CO2 absorbents in mechanical ventilators for breathing circuit is expected to drive anaesthesia CO2 absorbent market growth.

Recent Development

• In December 2020, The EchoGlo peripheral nerve block portfolio has been launched by Smiths Medical, a major medical device producer. This addition to the Portex pain management product line provides customers with a complete regional anaesthetic solution, from the pump to the patient.

Global Anesthesia CO2 Absorbent Market Scope

The anesthesia CO2 absorbent market is segmented on the basis of product type, application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Application

• Hospital
• Clinic

Product

• Sodasorb
• Soda Lime
• Others

Anesthesia CO2 Absorbent Market Regional Analysis/Insights

The anesthesia CO2 absorbent market is analysed and market size insights and trends are provided by country, product, application as referenced above.

The countries covered in the anesthesia CO2 absorbent market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America anesthesia CO2 absorbent dominating the market due to growing volumes of surgeries in the region, increasing incidences of road mishaps, growing geriatric populace, and increasing medical tourism.

Asia-Pacific anesthesia CO2 absorbent market is expected to register the highest CAGR during the forecast period, mainly due to the region’s rapidly advancing healthcare infrastructure.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Anesthesia CO2 Absorbent Market Share Analysis

The anesthesia CO2 absorbent market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to anesthesia CO2 absorbent market.

Some of the major players operating in the anesthesia CO2 absorbent market are:

• BD (U.S)
• Drägerwerk AG & Co. KGaA (Germany)
• Smiths+Medical (U.S)
• Allied Healthcare Organisation (U.K)
• Armstrong Medical (U.K)
• Micropore (U.K)
• Intersurgical Ltd. (U.S)
• General Electric (U.S.)
• Vyaire Medical, Inc. (U.S.)
• Armstrong Medical (U.K.)
• Molecular Products Group, Ltd. (U.K)
• Micropore, Inc. (U.S.)
• Lowenstein Medical UK, Ltd. (U.K)
• Atrasorb (Brazil)

SKU-68647